Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma
-
Published:2021-12
Issue:
Volume:
Page:
-
ISSN:0168-8278
-
Container-title:Journal of Hepatology
-
language:en
-
Short-container-title:Journal of Hepatology
Author:
Cheng Ann-Lii,
Qin Shukui,
Ikeda MasafumiORCID,
Galle Peter R.ORCID,
Ducreux Michel,
Kim Tae-You,
Lim Ho Yeong,
Kudo MasatoshiORCID,
Breder Valeriy,
Merle Philippe,
Kaseb Ahmed O.,
Li DanengORCID,
Verret Wendy,
Ma Ning,
Nicholas Alan,
Wang Yifan,
Li Lindong,
Zhu Andrew X.,
Finn Richard S.ORCID
Cited by
703 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献